FONAR

NEWS    
For Immediate Release   The Inventor of MR Scanning™
Contact: Daniel Culver   An ISO 9001 Company
Director of Communications   Melville, New York 11747
E-mail: investor@fonar.com   Phone: (631) 694-2929
www.fonar.com   Fax: (631) 390-1709

 

FONAR Announces Fiscal 2015 Year End Earnings

  • 23% Increase of Fiscal 2015 Diluted Net Income per Common Share available to Common Shareholders to $1.95, versus prior year
  • 15% Increase of Fiscal 2015 Net Income to $15.4 million, versus prior year
  • 5 % Increase of Fiscal 2015 Income from Operations to $12.9 million, versus prior year
  • Increase of Fiscal 2015 net revenues to $69.1 million, versus prior year

MELVILLE, NEW YORK, September 14, 2015 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, reported today its fiscal 2015 results for the year ended June 30, 2015. The Company is known as the first Company to invent and manufacture an MRI (Magnetic Resonance) scanner. Leading the list of FONAR’s most recent patented inventions is its technology enabling UPRIGHT® full weight-bearing MRI imaging for the first time on all the gravity sensitive regions of the human anatomy, e.g. the spine, brain, hip, knee, ankle, foot, shoulder, and pelvis. The FONAR UPRIGHT® Multi-Position™ MRI scanner is the world’s only MRI scanner licensed under FONAR’s multiple UPRIGHT® MRI patents to scan all the patient’s body parts in their normal fully weight-bearing UPRIGHT® position.

Financial Highlights

Net income increased 15% to $15.4 million for the fiscal year ended June 30, 2015. This compares with $13.4 million for the fiscal year ended June 30, 2014.

Income from operations increased 5% to $12.9 million for the fiscal year ended June 30, 2015. This compares with $12.3 million for the fiscal year ended June 30, 2014.

Basic net income per common share available to common shareholders increased 23% to $2.00 for the fiscal year ended June 30, 2015 as compared to $1.62 for the fiscal year ended June 30, 2014.

Diluted net income per common share available to common shareholders increased 23% to $1.95 for the fiscal year ended June 30, 2015 as compared to $1.58 for the fiscal year ended June 30, 2014.

Revenues increased to $69.1 million for the fiscal year ended June 30, 2015. This compares to $68.5 million for the fiscal year ended June 30, 2014.

 

 
 

 

FONAR  
  Page 2 of 8

For the year ended June 30, 2015, the revenues from the management of the diagnostic imaging center segment, consisting of patient and management fee revenue, and less the provision for bad debt for patient revenue, was $57.6 million as compared to $56.4 million one year earlier.

At June 30, 2015, total assets were $76.5 million, as compared to $76.8 million one year earlier.

At June 30, 2015, total cash and cash equivalents were $9.4 million, as compared to $10.0 million one year earlier.

At June 30, 2015, total liabilities were $25.7 million, as compared to $30.9 million one year earlier.

At June 30, 2015, total current liabilities were $18.8 million, as compared to $20.9 million one year earlier.

Significant Events

On January 8, 2015, the Company purchased 20% of the Class A members ownership interest in Health Diagnostic Management, LLC., (HDM) for a cost of approximately $5.0 million. After this cash transaction, the Company’s ownership interest in HDM is 60.4%.

On May 1, 2015, the Company repaid a portion of the Class A Stockholders capital contribution of approximately $1.1 million. As a result, the Company’s subsidiary, HMCA, owns a 96% interest in Imperial Management Services.

Highlighted in a press release (www.fonar.com/news/050515.htm) earlier this year, a 94-page, seven chapter monograph entitled, “The Craniocervical Syndrome and MRI” was published by S. Karger, AG, (www.karger.com/Book/Home/261956). It examines the impact of rapid advances in MRI that are transforming the treatment of patients suffering from the craniocervical syndrome (CCS). It is written by leading international experts in the field to provide practitioners with a better understanding of the subtle anatomy and MRI appearances at the craniocervical junction, the junction of the human skull with the first two vertebra of the spine, the atlas vertebra (C-1), spine vertebra #1 and the axis vertebra (C-2), spine vertebra # 2 that provides the axis of rotation for the head. The Craniocervical Syndrome monograph compiles the symptoms and medical disabilities that result from common injuries to the head and neck, e.g. 1.2 million automobile whiplash injuries occurring annually in the U.S. Of particular importance, highlighted by the authors, is the newly discovered physiologic importance of the dynamic role of the cerebrospinal fluid (CSF) circulation throughout the brain and spinal column, which is circulating from the brain to the bottom of the spine at the rate of 32 quarts per day. With the advent of FONAR’s new technology for capturing realtime video visualization (“movies”) of the CSF as it moves in and out of the UPRIGHT® brain, the widespread pressure of the obstructions to the CSF flow in and out of the brain as a result of trauma injuries to the neck, is now believed by FONAR and scientists working in collaboration with FONAR to be playing a major role in the genesis of the neurodegenerative diseases such as Alzheimer’s, Childhood Autism, Parkinson’s, Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). It directs attention to the revolutionary importance of FONAR’s new UPRIGHT® MRI imaging technology and the prospect of significantly relieving the suffering of the millions of patients afflicted with these disorders.

 
 

  FONAR  
  Page 3 of 8

 

Management Discussion

Raymond V. Damadian, M.D., president and chairman of Fonar Corporation, said, “the Company has prospered significantly over the past few years as evidenced by recent increases in diluted earnings per share of 23% in fiscal 2015, 18% in fiscal 2014 and 47% in fiscal 2013. Specifically, for fiscal 2015, our diluted net income per common share, available to common shareholders, increased 23% to $1.95 versus fiscal 2014. For fiscal 2014, diluted net income per common share, available to common shareholders, increased 18% to $1.58 versus fiscal 2013. For fiscal 2013, diluted net income per common share, available to common shareholders, increased 47% to $1.34 versus fiscal 2012 when it was $0.91.”

“Revenue growth continues as the Company purchases more of the ownership interests of our minority partners. HMCA, LLC, may be expected to expand with more diagnostic imaging centers. Scan volume is steadily increasing at our current 24 imaging centers as the medical community learns firsthand from the improved outcomes of their patients of the unique diagnostic benefits of the FONAR UPRIGHT® Multi-Position™ fully weight-loaded MRI. We also continue to sell the FONAR UPRIGHT® Multi-Position MRI to new customers,” said Dr. Damadian.

About FONAR

FONAR (NASDAQ:FONR), Melville, NY, The Inventor of MR Scanning™, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world’s first commercial MRI in 1980, and went public in 1981. FONAR’s stellar product is the FONAR UPRIGHT® MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient’s problem that other scanners cannot because they are lie-down and ”weightless” only scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, “If the patient is claustrophobic in this scanner, they’ll be claustrophobic in my parking lot.” Approximately 85% of patients are scanned sitting while they watch a 42” flat screen TV. FONAR is headquartered on Long Island, New York.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Dynamic™, Spondylometry™, CSP™, and Landscape™, are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.

 
 

FONAR

  Page 4 of 8

 

CONSOLIDATED BALANCE SHEETS

 

 

ASSETS

 

   June 30,
   2015  2014
Current Assets:          
Cash and cash equivalents  $9,448,798   $9,951,736 
Accounts receivable – net of allowances for doubtful accounts of $362,362 and $257,362 at June 30, 2015 and 2014, respectively   3,790,981    4,450,125 
Medical receivables –net of allowances for doubtful accounts of $25,688,000 and $12,917,751 at June 30, 2015 and 2014, respectively   9,082,319    8,807,856 
Management and other fees receivable – net of allowances for doubtful accounts of $13,271,651 and $10,901,619 at June 30, 2015 and 2014, respectively   14,057,962    11,970,388 
Management and other fees receivable – related medical practices – net of allowances for doubtful accounts of $403,047 at June 30, 2015 and 2014   3,507,204    3,426,982 
Costs and estimated earnings in excess of billings on uncompleted contracts   681,660    759,809 
Inventories   2,191,849    2,443,536 
Prepaid expenses and other current assets   860,040    1,011,358 
           
Total Current Assets   43,620,813    42,821,790 
Deferred income tax asset   8,423,306    5,740,287 
Property and Equipment – Net   12,901,195    15,029,729 
Goodwill   1,767,098    1,767,098 
Other Intangible Assets – Net   8,950,160    10,508,843 
Other Assets   829,505    922,096 
Total Assets  $76,492,077   $76,789,843 

 

 

 

 

 

 
 

 

FONAR

  Page 5 of 8

 

CONSOLIDATED BALANCE SHEETS

 

 

LIABILITIES

 

 

 

   June 30,
   2015  2014
Current Liabilities:          
Current portion of long-term debt and capital leases  $2,490,146   $2,890,816 
Accounts payable   1,782,442    2,481,997 
Other current liabilities   8,252,633    8,750,286 
Unearned revenue on service contracts   4,187,401    4,730,962 
Customer deposits   1,937,813    1,926,813 
Billings in excess of costs and estimated earnings on uncompleted contracts   142,217    142,217 
Total Current Liabilities   18,792,652    20,923,091 
Long-Term Liabilities:          
Deferred income tax liability   510,492    583,990 
Due to related medical practices   236,920    234,581 
Long-term debt and capital leases, less current portion   5,699,302    8,481,830 
Other liabilities   469,198    659,759 
Total Long-Term Liabilities   6,915,912    9,960,160 
Total Liabilities   25,708,564    30,883,251 

 

 

 

 

 

 

 

 

 

 

 
 

 

FONAR

  Page 6 of 8

 

CONSOLIDATED BALANCE SHEETS

 

STOCKHOLDERS' EQUITY

 

 

   June 30,
   2015  2014
Stockholders' Equity:          
 Class A non-voting preferred stock $.0001 par value; 453,000 shares authorized at June 30, 2015 and 2014, 313,438 issued and outstanding at June 30, 2015 and 2014  $31   $31 
 Preferred stock $.001 par value; 567,000 shares authorized at June 30, 2015 and 2014, issued and outstanding – none   —      —   
 Common stock $.0001 par value; 8,500,000 shares authorized at June 30, 2015 and 2014, 6,062,483 and 6,057,483 issued at June 30, 2015 and 2014, respectively; 6,050,840 and 6,045,840 outstanding at June 30, 2015 and 2014, respectively   607    606 
 Class B common stock (10 votes per share) $.0001 par value; 227,000 shares authorized at June 30, 2015 and 2014, 146 issued and outstanding at June 30, 2015 and 2014   —      —   
 Class C common stock (25 votes per share) $.0001 par value; 567,000 shares authorized at June 30, 2015 and 2014, 382,513 issued and outstanding at June 30, 2015 and 2014   38    38 
 Paid-in capital in excess of par value   175,447,586    175,284,437 
 Accumulated deficit   (136,348,635)   (149,259,286)
 Notes receivable from employee stockholders   (31,495)   (38,828)
Treasury stock, at cost – 11,643 shares of common stock at  June 30, 2015 and 2014   (675,390)   (675,390)
Total Fonar Corporation’s Stockholders’ Equity   38,392,742    25,311,608 
Noncontrolling interests   12,390,771    20,594,984 
Total Stockholders' Equity   50,783,513    45,906,592 
Total Liabilities and Stockholders' Equity  $76,492,077   $76,789,843 

 

 
 

 

FONAR

  Page 7 of 8

CONSOLIDATED STATEMENTS OF INCOME

   For the Years
Ended June 30,
Revenues  2015  2014
Product sales – net  $1,820,979   $1,877,932 
Service and repair fees – net   9,549,316    10,082,631 
Service and repair fees – related parties – net   110,000    110,000 
Patient fee revenue, net of contractual allowances and discounts   28,153,598    24,307,192 
Provision for bad debts for patient fee   (12,770,249)   (10,333,082)
Management and other fees – net   34,805,627    34,839,969 
Management and other fees – related medical practices – net   7,381,725    7,620,835 
Total Revenues – Net   69,050,996    68,505,477 
Costs and Expenses          
Costs related to product sales   1,882,230    1,067,120 
Costs related to service and repair fees   2,189,373    2,496,985 
Costs related to service and repair fees – related parties   25,220    27,242 
Costs related to patient fee revenue   7,939,524    7,670,484 
Costs related to management and other fees   20,970,116    20,851,065 
Costs related to management and other fees – related medical practices   5,397,818    5,134,553 
Research and development   1,812,398    1,760,821 
Selling, general and administrative,  inclusive of compensatory element of stock issuances of $53,200 and $223,000 for the years ended June 30, 2015 and 2014, respectively   13,459,408    15,388,239 
Provision for bad debts   2,475,032    1,806,299 
Total Costs and Expenses   56,151,119    56,202,808 
Income from Operations   12,899,877    12,302,669 
Other Income and (Expenses):          
Interest expense   (702,095)   (884,541)
Investment income   225,270    238,928 
Other income (expense) – net   394,810    (608,599)
Income before benefit for income taxes and noncontrolling interests   12,817,862    11,048,457 
Benefit for Income Taxes   2,612,521    2,348,312 
Net Income  $15,430,383   $13,396,769 
Net Income – Noncontrolling Interests   (2,519,732)   (3,000,639)
Net Income – Controlling Interests  $12,910,651   $10,396,130 
 
 

FONAR

  Page 8 of 8

 

 

CONSOLIDATED STATEMENTS OF INCOME (Continued)

 

 

 

   For the Years Ended June 30,
   2015  2014

Net Income Available to Common Stockholders

  $12,071,670   $9,720,030 
Net Income Available to Class A Non-Voting Preferred Stockholders  $625,309   $503,911 
Net Income Available to Class C Common Stockholders  $213,672   $172,189 
Basic Net Income Per Common Share Available to Common Stockholders  $2.00   $1.62 
Diluted Net Income Per Common Share Available to Common Stockholders  $1.95   $1.58 

Basic and Diluted Income Per Share – Common C

  $0.56   $0.45 
Weighted Average Basic Shares Outstanding – Common Stockholder   6,050,632    6,009,822 
Weighted Average Diluted Shares Outstanding – Common Stockholder   6,178,136    6,137,326 
Weighted Average Basic Shares Outstanding – Class C Common   382,513    382,513 
Weighted Average Diluted Shares Outstanding – Class C Common   382,513    382,513 

 

 

 

 

 

 

 

 

 

 

 

#

 


The following information was filed by Fonar Corp (FONR) on Tuesday, September 15, 2015 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Fonar Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Fonar Corp.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

FREE Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue for FREE

Log in with your credentials

or    

Forgot your details?

Create Account